Abbott's MDx Sales Rise 23 Percent in Q2 2010

The firm also said that it expects to launch more than 12 new molecular diagnostic products over the next two to three years.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories